Cutler Group LP Cassava Sciences Inc Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	SELL	$18.44 - $26.41 $497,880 - $713,070	-27,000 Reduced 50.66%	26,300 $91,000
Q4 2023 Jan 18, 2024	BUY	$12.64 - $30.11 $575,120 - $1.37 Million	45,500 Added 583.33%	53,300 $105,000
Q3 2023 Nov 07, 2023	SELL	$16.64 - $25.32 $68,224 - $103,812	-4,100 Reduced 34.45%	7,800 $15,000
Q2 2023 Jul 18, 2023	SELL	$21.59 - $27.88 $278,511 - $359,652	-12,900 Reduced 52.02%	11,900 $46,000
Q1 2023 May 01, 2023	SELL	$23.46 - $36.44 $2.24 Million - $3.48 Million	-95,600 Reduced 79.4%	24,800 $55,000
Q4 2022 Feb 07, 2023	BUY	$27.82 - $44.16 $492,414 - $781,631	17,700 Added 17.23%	120,400 $446,000
Q3 2022 Oct 25, 2022	BUY	$16.33 - $51.06 $792,004 - $2.48 Million	48,500 Added 89.48%	102,700 $1.15 Million
Q2 2022 Aug 04, 2022	SELL	$17.22 - $38.47 $554,484 - $1.24 Million	-32,200 Reduced 37.27%	54,200 $372,000
Q1 2022 Apr 14, 2022	SELL	$32.6 - $53.05 $541,160 - $880,630	-16,600 Reduced 16.12%	86,400 $760,000
Q4 2021 Jan 18, 2022	SELL	$36.77 - $90.91 $1.23 Million - $3.05 Million	-33,500 Reduced 24.54%	103,000 $503,000
Q3 2021 Oct 26, 2021	BUY	$41.79 - $135.3 $3.62 Million - $11.7 Million	86,600 Added 173.55%	136,500 $1.01 Million
Q2 2021 Jul 19, 2021	BUY	$32.15 - $89.72 $147,890 - $412,712	4,600 Added 10.15%	49,900 $983,000
Q1 2021 Apr 26, 2021	BUY	$7.09 - $87.95 $293,526 - $3.64 Million	41,400 Added 1061.54%	45,300 $176,000
Q4 2020 Jan 21, 2021	SELL	$6.79 - $12.25 $52,962 - $95,550	-7,800 Reduced 66.67%	3,900 $6,000
Q3 2020 Oct 27, 2020	SELL	$2.86 - $11.51 $28,600 - $115,100	-10,000 Reduced 46.08%	11,700 $48,000
Q2 2020 Jul 22, 2020	BUY	$2.04 - $9.64 $43,248 - $204,368	21,200 Added 4240.0%	21,700 $2,000
Q1 2020 May 07, 2020	BUY	$3.26 - $9.65 $1,630 - $4,825	500 New	500 $0

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

Black Rock Inc. New York, NY

3.22M
Shares

$12.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.52M
Shares

$9.69 Million
0.0% of portfolio
State Street Corp Boston, MA

1.16M
Shares

$4.46 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.01M
Shares

$3.87 Million
0.0% of portfolio
Gallacher Capital Management LLC Lone Tree, CO

580K
Shares

$2.23 Million
7.83% of portfolio

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $154M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account